Related Experiment Video
Updated: May 26, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Regulated cell death: a multidimensional regulatory network in the pathogenesis of renal fibrosis
Wen Li1, Liang Zhou1, Jinji Zhang1
1Department of Clinical Trial, Shaanxi Provincial People's Hospital, No. 256 Youyi West Road, Beilin District, Xi'an, 710068, Shaanxi, China.
Abstract:
Increasing evidence indicates that regulated cell death (RCD), such as apoptosis, anoikis, autophagy, pyroptosis, necroptosis, ferroptosis and cuproptosis, plays crucial roles in renal tissue injury and the progression of fibrosis by promoting inflammatory responses and extracellular matrix deposition. Therefore, elucidating the molecular mechanisms of different types of RCD is essential for treating patients with renal fibrosis. This review comprehensively presents the distinct and interactive roles of RCD in renal fibrosis pathogenesis and elucidates the crosstalk among different forms of RCD and core fibrotic signaling pathways. Moreover, we analyzed clinically promising RCD-related therapeutic targets and identified future research directions, thereby providing a theoretical basis for the clinical treatment of renal fibrosis patients. To mitigate the threat of compensatory crosstalk between RCD pathways during clinical translation, the development of drugs that simultaneously target multiple forms of RCD may offer a novel approach for precise renal fibrosis treatment.
Insights
Regulated cell death (RCD) pathways are key in kidney fibrosis. Targeting multiple RCD types offers a promising strategy for precise renal fibrosis treatment.
Area of Science:
- Nephrology
- Cell Biology
- Pathology
Background:
- Regulated cell death (RCD) pathways, including apoptosis, pyroptosis, and ferroptosis, are increasingly implicated in renal tissue injury and fibrosis.
- These processes promote inflammation and extracellular matrix deposition, driving kidney fibrosis progression.
Purpose of the Study:
- To comprehensively review the distinct and interactive roles of various RCDs in renal fibrosis pathogenesis.
- To elucidate the crosstalk between different RCDs and fibrotic signaling pathways.
- To identify promising RCD-related therapeutic targets for renal fibrosis.
Main Methods:
- Literature review and synthesis of existing research on RCD and renal fibrosis.
- Analysis of molecular mechanisms underlying RCD in kidney injury.
- Evaluation of therapeutic strategies targeting RCD pathways.
Main Results:
- RCD plays a critical role in renal fibrosis through inflammatory responses and extracellular matrix deposition.
- Complex crosstalk exists among different RCD pathways and core fibrotic signaling.
- Several RCD-related targets show clinical promise for treating renal fibrosis.
Conclusions:
- Understanding RCD mechanisms is crucial for developing effective treatments for renal fibrosis.
- Simultaneous targeting of multiple RCD pathways may overcome compensatory crosstalk for precise therapeutic intervention.
- Further research is needed to translate these findings into clinical practice for renal fibrosis patients.
Related Concept Videos
Cirrhosis II: Pathophysiology
Acute Kidney Injury II: Pathophysiology
Regulation of the Unfolded Protein Response
Diabetic Nephropathy
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IlI: Cellular Death
